This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Tissue Genesis, Inc.
Tissue Genesis, Inc., a pioneering entity in the regenerative medicine sector, is headquartered in the United States. Founded in 2006, the company has established itself as a leader in the development of innovative tissue engineering solutions, particularly in the fields of cellular therapies and regenerative medicine. With a focus on harnessing the potential of adipose-derived stem cells, Tissue Genesis offers unique products and services that facilitate advanced healing and tissue regeneration. Their proprietary technologies are designed to enhance patient outcomes in various medical applications, setting them apart in a competitive market. Recognised for their commitment to quality and innovation, Tissue Genesis continues to expand its operational reach, contributing significantly to the advancement of regenerative therapies and solidifying its position as a key player in the industry.
DitchCarbon Score
How does Tissue Genesis, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tissue Genesis, Inc.'s score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tissue Genesis, Inc.'s reported carbon emissions
In 2022, Tissue Genesis, Inc. reported total carbon emissions of approximately 491,645,000 kg CO2e. This figure includes 7,045,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources. The company also recorded 21,338,000 kg CO2e in Scope 2 emissions, primarily from purchased electricity. Notably, the majority of their emissions, about 463,262,000 kg CO2e, fell under Scope 3, which includes indirect emissions from the value chain. Key contributors to Scope 3 emissions were purchased goods and services (159,362,000 kg CO2e) and downstream transportation and distribution (104,881,000 kg CO2e). Comparatively, in 2021, Tissue Genesis, Inc. had total emissions of approximately 505,075,000 kg CO2e, indicating a reduction of about 13,430,000 kg CO2e year-on-year. This reduction reflects a commitment to improving their environmental impact, although no specific reduction targets or climate pledges have been documented. Tissue Genesis, Inc. operates independently without cascading emissions data from a parent company, ensuring that their reported figures are solely reflective of their own operations. The company continues to focus on understanding and managing its carbon footprint as part of its broader climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tissue Genesis, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
